Furthermore, SCARF1 expression could potentially be targeted to alter the inflammatory status of the tumor microenvironment, shifting it toward an anti-tumoral immune response and supporting immunotherapy regimes for HCC. The gene discussed is SCARF1; the disease is hepatocellular carcinoma.